Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression

Brain, Behavior, and Immunity

Volumn 44, Issue , 2015, Pages 28-31

  Chang, Jane Pei Chen ^a,b   Chang, Shih Sheng ^a,b   Yang, Hui Ting ^c   Palani, Mahalakshmi ^a   Chen, Chun Ping ^a   Su, Kuan Pin ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

CVDs; Depression; Omega 3; Somatic

Indexed keywords

C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; UNSATURATED FATTY ACID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; ELECTROCARDIOGRAM; ERYTHROCYTE; FEMALE; HAMILTON SCALE; HUMAN; MALE; MIDDLE AGED; SECONDARY ANALYSIS; AGED; BLOOD; COMPLICATION;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84918524428     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.11.005     Document Type: Article

References (36)

1. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willett W.C., Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 2002, 346:1113-1118.
2. Anfossi G., Trovati M. Role of catecholamines in platelet function: pathophysiological and clinical significance. Eur. J. Clin. Invest. 1996, 26:353-370.
3. Blacker D. Psychiatric rating scales. Comprehensive Textbook of Psychiatry 2005, 929-955. Lippincott Williams & Wilkins, Philadelphia. eighth ed. B.J. Sadock, V. Sadock (Eds.).
4. Bucher H.C., Hengstler P., Schindler C., Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am. J. Med. 2002, 112:298-304.
5. Carney R.M., Freedland K.E., Veith R.C., Cryer P.E., Skala J.A., Lynch T., Jaffe A.S. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol. Psychiatry 1999, 45:458-463.
6. Chang J.P., Su K.P. The lipid raft hypothesis: the relation among omega-3 fatty acids, depression and cardiovascular diseases [Review]. Taiwanese J. Psychiatry 2010, 24:168-180.
7. Chang J.P., Chen Y.T., Su K.P. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) in cardiovascular diseases (CVDs) and depression: the missing link?. Cardiovasc. Psychiatry Neurol. 2009, 2009:725310.
8. Chiu C.C., Huang S.Y., Shen W.W., Su K.P. Omega-3 fatty acids for depression in pregnancy. Am. J. Psychiatry 2003, 160:385.
9. Chrysohoou C., Panagiotakos D.B., Pitsavos C., Skoumas J., Krinos X., Chloptsios Y., Nikolaou V., Stefanadis C. Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region - the ATTICA study. Am. J. Clin. Nutr. 2007, 85:1385-1391.
10. Ford D.E., Mead L.A., Chang P.P., Cooper-Patrick L., Wang N.Y., Klag M.J. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch. Intern. Med. 1998, 158:1422-1426.
11. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993, 270:1819-1825.
12. Frasure-Smith N., Lesperance F., Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol. Psychiatry 2004, 55:891-896.
13. Gehi A., Mangano D., Pipkin S., Browner W.S., Whooley M.A. Depression and heart rate variability in patients with stable coronary heart disease: findings from the heart and soul study. Arch. Gen. Psychiatry 2005, 62:661-666.
14. Grimsgaard S., Bonaa K.H., Hansen J.B., Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am. J. Clin. Nutr. 1997, 66:649-659.
15. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12:123-137.
16. Hibbeln J.R., Nieminen L.R., Blasbalg T.L., Riggs J.A., Lands W.E. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am. J. Clin. Nutr. 2006, 83:1483S-1493S.
17. Lespérance F., Frasure-Smith N., Koszycki D., Laliberté M.A., van Zyl L.T., Baker B., Swenson J.R., Ghatavi K., Abramson B.L., Dorian P., Guertin M.C., CREATE Investigators Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian cardiac randomized evaluation of antidepressant an psychotherapy efficacy (CREATE) trial. JAMA 2007, 297:367-379.
18. Lin P.Y., Su K.P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry 2007, 68:1056-1061.
19. Lin P.Y., Huang S.Y., Su K.P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol. Psychiatry 2010, 68:140-147.
20. Murray C.J., Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997, 349:1436-1442.
21. Musselman D.L., Nemeroff C.B. Depression and endocrine disorders: focus on the thyroid and adrenal system. Br. J. Psychiatry Suppl. 1996, 123-128.
22. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 1998, 55:580-592.
23. Peet M., Murphy B., Shay J., Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry 1998, 43:315-319.
24. Ramasubbu R., Beaulieu S., Taylor V.H., Schaffer A., McIntyre R.S., Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles. Ann. Clin. Psychiatry 2012, 24:82-90.
25. Schleifer S.J., Macari-Hinson M.M., Coyle D.A., Slater W.R., Kahn M., Gorlin R., Zucker H.D. The nature and course of depression following myocardial infarction. Arch. Intern. Med. 1989, 149:1785-1789.
26. Serebruany V.L., Glassman A.H., Malinin A.I., Sane D.C., Finkel M.S., Krishnan R.R., Atar D., Lekht V., O'Connor C.M. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul. Fibrinolysis 2003, 14:563-567.
27. Serres F., Azorin J.M., Valli M., Jeanningros R. Evidence for an increase in functional platelet 5-HT2A receptors in depressed patients using the new ligand [125I]-DOI. Eur. Psychiatry 1999, 14:451-457.
28. Su K.P. Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression. Asia. Pac. J. Clin. Nutr. 2008, 17:151-157.
29. Su K.P., Huang S.Y., Chiu C.C., Shen W.W. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur. Neuropsychopharmacol. 2003, 13:267-271.
30. Su K.P., Huang S.Y., Peng C.Y., Lai H.C., Huang C.L., Chen Y.C., Aitchison K.J., Pariante C.M. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol. Psychiatry 2010, 67:550-557.
31. Su K.P., Lai H.C., Yang H.T., Su W.P., Peng C.Y., Chang J.P., Chang H.C., Pariante C.M. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol. Psychiatry 2014, 76:559-566.
32. Thombs B.D., Bass E.B., Ford D.E., Stewart K.J., Tsilidis K.K., Patel U., Fauerbach J.A., Bush D.E., Ziegelstein R.C. Prevalence of depression in survivors of acute myocardial infarction. J. Gen. Intern. Med. 2006, 21:30-38.
33. Wassertheil-Smoller S., Shumaker S., Ockene J., Talavera G.A., Greenland P., Cochrane B., Robbins J., Aragaki A., Dunbar-Jacob J. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch. Intern. Med. 2004, 164:289-298.
34. Whelton S.P., He J., Whelton P.K., Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am. J. Cardiol. 2004, 93:1119-1123.
35. Williams J.B. A structured interview guide for the Hamilton depression rating scale. Arch. Gen. Psychiatry 1988, 45:742-747.
36. Zimmerman M., Martinez J.H., Young D., Chelminski I., Dalrymple K. Severity classification on the Hamilton depression rating scale. J. Affect. Disord. 2013, 150:384-388.